Wellgistics Health partners with DataVault AI to develop blockchain-based PharmacyChain for prescription drug tracking

Wellgistics Health, Inc.

SaaS agreement with DataVault AI (NASDAQ: DVLT) to develop PharmacyChain, a manufacturer-to-patient blockchain platform.
Beta testing expected in first half of 2026; profit-sharing license agreement to be finalized in Q4 2025.
Platform aims to improve prescription tracking, insurance reimbursement, and patient adherence in $639B prescription drug market.
DataVault AI's patents cover blockchain data scoring, valuation, and monetization; platform to enable secure data transfer for pharmacists.
Wellgistics expects PharmacyChain to drive market share gains and expansion into new markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.